Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

18 structures for Q8N5Z0

Entry ID Method Resolution Chain Position Source
2QLR X-ray 230 A A/B/C/D 1-425 PDB
2R2N X-ray 195 A A/B/C/D 1-425 PDB
2VGZ X-ray 230 A A/B 2-425 PDB
2XH1 X-ray 210 A A/B 1-425 PDB
3DC1 X-ray 250 A A/B/C/D 1-425 PDB
3UE8 X-ray 322 A A/B 1-425 PDB
4GDY X-ray 289 A A/B 1-425 PDB
4GE4 X-ray 241 A A/B 1-425 PDB
4GE7 X-ray 210 A A/B 1-425 PDB
4GE9 X-ray 243 A A/B/C/D 1-425 PDB
4GEB X-ray 215 A A/B 1-425 PDB
5EFS X-ray 183 A A 1-425 PDB
5EUN X-ray 182 A A 1-425 PDB
5TF5 X-ray 181 A A/B 1-425 PDB
6D0A X-ray 147 A A 1-425 PDB
6T8P X-ray 202 A A/B 1-425 PDB
6T8Q X-ray 251 A A 1-425 PDB
AF-Q8N5Z0-F1 Predicted AlphaFoldDB

221 variants for Q8N5Z0

Variant ID(s) Position Change Description Diseaes Association Provenance
CA358757759
rs1425816123
4 A>G No ClinGen
gnomAD
rs1467125404
CA358757763
4 A>T No ClinGen
gnomAD
rs1191628150
CA358757756
5 R>W No ClinGen
gnomAD
CA109985205
rs1017430781
9 A>T No ClinGen
TOPMed
gnomAD
CA109985204
rs1040775617
11 S>N No ClinGen
gnomAD
CA3139642
rs751685780
12 A>T No ClinGen
ExAC
gnomAD
rs1199772636
CA358757682
16 P>L No ClinGen
gnomAD
rs1320649412
CA358757677
17 S>C No ClinGen
gnomAD
CA358757676
rs1320649412
17 S>F No ClinGen
gnomAD
rs1255576778
CA358757661
20 R>W No ClinGen
TOPMed
gnomAD
rs1217522047
CA358757645
22 M>I No ClinGen
gnomAD
rs766029947
CA3139614
24 D>E No ClinGen
ExAC
TOPMed
gnomAD
rs1482445104
CA358757222
25 I>V No ClinGen
gnomAD
CA109984977
rs768749259
27 S>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1339110095
CA358757178
28 R>K No ClinGen
TOPMed
rs1265427621
CA358757164
29 G>E No ClinGen
gnomAD
CA3139610
rs761367463
33 M>I No ClinGen
ExAC
gnomAD
CA3139609
rs777046313
35 S>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA358757052
rs1490727321
37 A>S No ClinGen
TOPMed
CA3139608
rs769204528
38 G>S No ClinGen
ExAC
gnomAD
CA109984971
rs930770122
39 G>D No ClinGen
Ensembl
rs973609669
CA109984970
41 P>Q No ClinGen
Ensembl
CA358756993
rs1209123754
42 N>S No ClinGen
gnomAD
rs747437640
CA3139607
45 M>T No ClinGen
ExAC
gnomAD
CA358756916
rs1220589433
47 P>R No ClinGen
gnomAD
CA3139604
rs746038548
52 V>A No ClinGen
ExAC
TOPMed
gnomAD
CA3139605
rs772428576
52 V>I No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 54 T>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA109984965
rs921999105
54 T>S No ClinGen
TOPMed
gnomAD
rs1242683262
CA358756857
55 V>A No ClinGen
TOPMed
rs1322027631
CA358756851
56 E>G No ClinGen
gnomAD
CA358756843
rs1448811842
57 N>S No ClinGen
TOPMed
CA358756827
rs1401709165
59 K>N No ClinGen
TOPMed
gnomAD
rs1440757922
CA358756829
59 K>R No ClinGen
gnomAD
rs1172181698
CA358756824
60 T>A No ClinGen
gnomAD
rs1386862575
CA358756813
61 I>M No ClinGen
TOPMed
rs201523439
CA3139603
62 Q>K No ClinGen
1000Genomes
ExAC
gnomAD
CA109984964
rs974776383
62 Q>R No ClinGen
Ensembl
CA3139602
rs757318974
63 F>S No ClinGen
ExAC
gnomAD
rs200677642
CA3139601
66 E>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA109984963
rs372381527
67 M>L No ClinGen
Ensembl
TCGA novel 71 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs751355240
CA3139598
76 P>L No ClinGen
ExAC
gnomAD
rs762619514
CA3139596
78 A>P No ClinGen
ExAC
gnomAD
CA358756580
rs1456458045
79 G>A No ClinGen
gnomAD
TCGA novel 80 I>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA358756420
rs1200059484
83 L>P No ClinGen
TOPMed
CA358756406
rs1362163974
85 S>F No ClinGen
gnomAD
CA358756381
rs1254397449
89 Q>* No ClinGen
TOPMed
rs1367388200
CA358756377
89 Q>H No ClinGen
TOPMed
gnomAD
CA358756374
rs1187409797
90 L>V No ClinGen
gnomAD
rs373520837
CA109984757
95 H>R No ClinGen
Ensembl
CA358756318
rs1184561713
97 P>L No ClinGen
gnomAD
rs1581598831
CA358756311
99 T>P No ClinGen
Ensembl
rs763621026
CA3139567
102 Y>C No ClinGen
ExAC
gnomAD
rs17852900
CA358756269
103 P>L No ClinGen
gnomAD
rs17852900
CA109984755
103 P>Q No ClinGen
gnomAD
CA358756280
rs1581598818
103 P>T No ClinGen
Ensembl
rs1471887450
CA358756239
106 Q>K No ClinGen
TOPMed
rs1182519128
CA358756220
107 G>R No ClinGen
TOPMed
gnomAD
CA3139565
rs565975733
109 M>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 111 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA358756131
rs1373200177
112 C>R No ClinGen
TOPMed
CA358756121
rs1187434478
112 C>S No ClinGen
gnomAD
rs774717219
CA3139562
114 T>I No ClinGen
ExAC
gnomAD
rs1256387233
CA358756058
115 S>C No ClinGen
gnomAD
CA358756005
rs368592471
118 Q>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA358755932
rs1389603283
123 K>R No ClinGen
TOPMed
rs748288798
CA3139538
126 E>Q No ClinGen
ExAC
gnomAD
rs776636092
CA358753570
CA3139537
127 M>I No ClinGen
ExAC
TOPMed
gnomAD
rs772003106
CA3139536
129 I>T No ClinGen
ExAC
gnomAD
COSM1053212
CA358753528
rs1561020255
130 N>D Variant assessed as Somatic; impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
Ensembl
NCI-TCGA
CA358753428
rs1164845687
135 V>A No ClinGen
TOPMed
gnomAD
rs1439397784
CA358753377
138 D>E No ClinGen
TOPMed
gnomAD
TCGA novel 142 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA358753309
rs1368167584
147 Q>R No ClinGen
TOPMed
rs1394874229
CA358752061
150 H>Y No ClinGen
gnomAD
CA109980469
rs778929860
151 P>S No ClinGen
Ensembl
CA358752020
rs1475000767
156 I>T No ClinGen
TOPMed
CA3139511
rs747749864
156 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA3139510
rs780966008
160 A>T No ClinGen
ExAC
gnomAD
TCGA novel 160 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3139509
rs754560049
161 S>N No ClinGen
ExAC
gnomAD
rs751031083
CA3139508
163 E>G No ClinGen
ExAC
gnomAD
TCGA novel 163 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA358751940
rs1257462322
168 P>S No ClinGen
gnomAD
CA358751932
rs1208284368
169 D>A No ClinGen
gnomAD
rs750792452
CA3139505
172 R>* No ClinGen
ExAC
gnomAD
rs267600079
CA109980441
172 R>K No ClinGen
gnomAD
rs267600079
CA358751916
172 R>T No ClinGen
gnomAD
rs1390948545
CA358751898
174 I>M No ClinGen
gnomAD
rs1304930129
CA358751900
174 I>T No ClinGen
gnomAD
rs765548846
CA3139504
177 R>I No ClinGen
ExAC
gnomAD
rs765548846
CA358751883
177 R>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA3139503
rs762045577
178 W>L No ClinGen
ExAC
CA358751843
rs1304752701
182 D>E Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs754110103
CA3139502
186 P>H No ClinGen
ExAC
TOPMed
gnomAD
rs754110103
CA358751815
186 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA358751798
rs1375181883
187 Q>H No ClinGen
gnomAD
CA358751806
rs1239347023
187 Q>R No ClinGen
gnomAD
rs764216489
CA3139501
189 N>D No ClinGen
ExAC
TOPMed
gnomAD
rs1010300173
CA109980409
189 N>I No ClinGen
Ensembl
CA358751764
rs1362627395
COSM1539899
190 T>A lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA109980402
rs891439256
COSM1695258
192 K>R skin [Cosmic] No ClinGen
cosmic curated
gnomAD
rs775374457
CA3139499
193 F>C No ClinGen
ExAC
gnomAD
rs1162961104
CA358751715
194 L>I No ClinGen
TOPMed
rs1257675827
CA358751693
195 Y>C No ClinGen
TOPMed
gnomAD
CA358751604
rs1485157498
199 N>D No ClinGen
gnomAD
CA3139496
rs773158625
210 S>G No ClinGen
ExAC
gnomAD
rs1052188225
CA358751361
211 E>D No ClinGen
TOPMed
gnomAD
rs1295236919
CA358751354
212 R>C No ClinGen
gnomAD
rs1355118438
CA358751325
214 K>E No ClinGen
TOPMed
gnomAD
CA358751248
rs1402318441
217 Y>C No ClinGen
gnomAD
rs1453241692
CA358750270
220 A>V No ClinGen
gnomAD
CA358749989
rs1212996721
222 K>R No ClinGen
gnomAD
TCGA novel 223 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 225 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA358749918
rs1581576448
228 I>K No ClinGen
Ensembl
rs773320216
CA358749919
228 I>L No ClinGen
ExAC
TOPMed
gnomAD
rs773320216
CA3139473
228 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA358749904
rs1269735608
230 D>N No ClinGen
gnomAD
TCGA novel 232 P>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA358749886
rs1170592122
232 P>R No ClinGen
TOPMed
CA358749888
rs1216507753
232 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA358749884
rs1337738611
233 Y>N No ClinGen
gnomAD
rs545729940
CA109979202
234 Y>C No ClinGen
gnomAD
CA3139471
rs776235647
237 Q>H No ClinGen
ExAC
gnomAD
CA3139469
rs557457280
239 N>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3139468
rs377049488
240 K>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs56350236
CA3139453
VAR_061005
243 V>I No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA3139452
rs753702003
245 T>R No ClinGen
ExAC
gnomAD
rs1172823661
CA358749762
249 M>V No ClinGen
gnomAD
rs1420207635
CA358749742
251 V>A No ClinGen
gnomAD
CA358749723
rs1272660297
254 R>H No ClinGen
gnomAD
rs1272660297
CA358749722
254 R>L No ClinGen
gnomAD
rs763749090
CA3139451
254 R>S No ClinGen
ExAC
gnomAD
CA358749721
rs1260243523
255 V>I No ClinGen
TOPMed
CA358749698
rs1179017809
258 A>D No ClinGen
gnomAD
rs1581574546
CA358749667
263 K>Q No ClinGen
Ensembl
rs1561013778
CA358749649
265 I>T No ClinGen
Ensembl
rs760496804
CA3139450
265 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA358749597
rs1429916730
271 I>M No ClinGen
gnomAD
rs1350460338
CA358749594
272 G>R No ClinGen
gnomAD
rs1326662965
CA358749565
276 G>D No ClinGen
gnomAD
TCGA novel 277 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 282 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs773871959
CA3139427
283 R>G Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1487212742
CA358749516
CA358749517
283 R>S No ClinGen
TOPMed
rs151231482
CA109978429
284 V>I No ClinGen
ESP
TCGA novel 285 I>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3139425
rs770474107
285 I>S No ClinGen
ExAC
gnomAD
CA109978423
rs1030363229
286 L>F No ClinGen
Ensembl
rs762489440
CA3139424
287 H>D No ClinGen
ExAC
gnomAD
rs773656274
CA3139423
288 I>M No ClinGen
ExAC
TOPMed
gnomAD
CA3139421
rs748477745
291 S>L No ClinGen
ExAC
gnomAD
rs781637765
CA3139420
294 H>L No ClinGen
ExAC
gnomAD
rs1198839695
CA358749365
299 N>D No ClinGen
gnomAD
rs1581573616
CA358749355
299 N>K No ClinGen
Ensembl
rs780401971
CA3139417
299 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA358749344
rs1293166075
300 Q>R No ClinGen
TOPMed
gnomAD
CA3139393
rs368676033
303 I>L No ClinGen
ESP
ExAC
gnomAD
CA358749217
rs1247831886
303 I>M No ClinGen
TOPMed
gnomAD
CA358749232
rs368676033
303 I>V No ClinGen
ESP
ExAC
gnomAD
rs142229838
CA3139392
304 S>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA358749139
rs779009351
308 H>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1581571680
CA358749149
308 H>Y No ClinGen
Ensembl
rs368304372
CA3139389
309 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs748131877
CA3139388
310 W>R No ClinGen
ExAC
TOPMed
gnomAD
rs992651734
CA109977913
318 H>Y No ClinGen
TOPMed
CA358748966
rs1561012545
319 V>I No ClinGen
Ensembl
rs781071963
CA3139387
320 D>G No ClinGen
ExAC
gnomAD
CA358748955
rs1261169161
320 D>N No ClinGen
gnomAD
rs754830422
CA3139386
321 R>K No ClinGen
ExAC
gnomAD
rs754848971
CA3139367
322 V>I No ClinGen
ExAC
gnomAD
rs545144600
CA3139366
323 I>T No ClinGen
1000Genomes
ExAC
gnomAD
CA3139365
rs779862124
325 F>I No ClinGen
ExAC
gnomAD
TCGA novel 325 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3139364
rs369026657
326 Y>C No ClinGen
ExAC
TOPMed
gnomAD
rs116082202
CA3139363
327 S>G No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs921398428
CA109977552
331 D>N No ClinGen
TOPMed
gnomAD
CA358747291
rs1366770056
338 D>E No ClinGen
TOPMed
rs147615281
CA3139360
342 T>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1455567118
CA358746806
347 W>R No ClinGen
gnomAD
rs145190544
CA3139340
348 H>R No ClinGen
ESP
ExAC
gnomAD
rs1191892782
CA358746757
349 V>D No ClinGen
gnomAD
TCGA novel 356 L>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1290781761
CA358746383
365 D>N No ClinGen
TOPMed
rs374628121
CA3139337
366 V>I No ClinGen
ESP
ExAC
gnomAD
CA358746197
rs1337799234
370 I>T No ClinGen
gnomAD
CA3139336
rs751810308
372 E>G No ClinGen
ExAC
gnomAD
CA358746101
rs1235619186
374 A>T No ClinGen
gnomAD
rs766590826
CA3139335
374 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA109976947
rs755665287
375 V>A No ClinGen
Ensembl
CA358746069
rs200099784
375 V>F No ClinGen
ExAC
TOPMed
gnomAD
rs200099784
CA3139332
375 V>I No ClinGen
ExAC
TOPMed
gnomAD
CA358746028
rs1292066664
376 K>N No ClinGen
TOPMed
rs1490064762
CA358746020
377 M>L No ClinGen
TOPMed
rs1561010805
CA358746014
377 M>T No ClinGen
Ensembl
CA358745961
rs1356225307
378 G>E No ClinGen
gnomAD
rs1160415427
CA358744624
379 V>L No ClinGen
gnomAD
TCGA novel 380 L>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1471723874
CA358744601
380 L>S No ClinGen
gnomAD
CA3139314
CA3139315
rs765444553
381 M>L No ClinGen
ExAC
gnomAD
rs762011420
CA3139313
382 L>F No ClinGen
ExAC
gnomAD
rs1446118862
CA358744528
383 P>L No ClinGen
TOPMed
rs1446118862
CA358744526
383 P>R No ClinGen
TOPMed
rs1486831747
CA358744490
385 N>S No ClinGen
gnomAD
CA358744429
rs1255889934
388 Y>H No ClinGen
gnomAD
CA3139311
rs767495658
389 V>I No ClinGen
ExAC
TOPMed
gnomAD
CA3139310
rs139598358
390 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs376931614
CA3139309
391 S>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA358744359
rs1293468526
392 S>T No ClinGen
gnomAD
rs1234770102
CA358744300
395 S>C No ClinGen
gnomAD
CA358744239
rs1283419238
397 Y>C No ClinGen
gnomAD
rs1455646499
CA358744048
404 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA358743858
rs1388012625
411 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA3139304
rs780525079
412 V>L No ClinGen
ExAC
gnomAD
CA3139303
rs780525079
412 V>M No ClinGen
ExAC
gnomAD
rs1220181330
CA358743650
415 Q>E No ClinGen
gnomAD
CA358743634
rs1487298471
416 V>I No ClinGen
TOPMed
gnomAD
CA358743552
rs1302880252
421 I>V No ClinGen
TOPMed

No associated diseases with Q8N5Z0

1 regional properties for Q8N5Z0

Type Name Position InterPro Accession
domain Aminotransferase, class I/classII 59 - 415 IPR004839

Functions

Description
EC Number 2.6.1.4 Transaminases
Subcellular Localization
  • Mitochondrion
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
mitochondrial matrix The gel-like material, with considerable fine structure, that lies in the matrix space, or lumen, of a mitochondrion. It contains the enzymes of the tricarboxylic acid cycle and, in some organisms, the enzymes concerned with fatty acid oxidation.

8 GO annotations of molecular function

Name Definition
2-aminoadipate transaminase activity Catalysis of the reaction: 2-oxoglutarate + L-2-aminoadipate = 2-oxoadipate + L-glutamate.
glycine:2-oxoglutarate aminotransferase activity Catalysis of the reaction: glycine + 2-oxoglutarate = glyoxylate + L-glutamate.
kynurenine-glyoxylate transaminase activity Catalysis of the reaction: L-kynurenine + glyoxylate = 4-(2-aminophenyl)-2,4-dioxobutanoate + glycine.
kynurenine-oxoglutarate transaminase activity Catalysis of the reaction: L-kynurenine + 2-oxoglutarate = 4-(2-aminophenyl)-2,4-dioxobutanoate + L-glutamate.
methionine-glyoxylate transaminase activity Catalysis of the reaction: L-methionine + glyoxylate = 4-methylthio-2-oxobutanoate + glycine.
protein homodimerization activity Binding to an identical protein to form a homodimer.
pyridoxal phosphate binding Binding to pyridoxal 5' phosphate, 3-hydroxy-5-(hydroxymethyl)-2-methyl4-pyridine carboxaldehyde 5' phosphate, the biologically active form of vitamin B6.
transaminase activity Catalysis of the transfer of an amino group to an acceptor, usually a 2-oxo acid.

6 GO annotations of biological process

Name Definition
2-oxoglutarate metabolic process The chemical reactions and pathways involving oxoglutarate, the dianion of 2-oxoglutaric acid. It is a key constituent of the TCA cycle and a key intermediate in amino-acid metabolism.
alpha-amino acid metabolic process The chemical reactions and pathways involving an alpha-amino acid.
biosynthetic process The chemical reactions and pathways resulting in the formation of substances; typically the energy-requiring part of metabolism in which simpler substances are transformed into more complex ones.
glutamate metabolic process The chemical reactions and pathways involving glutamate, the anion of 2-aminopentanedioic acid.
kynurenine metabolic process The chemical reactions and pathways involving kynurenine, the amino acid 3-(2-aminobenzoyl)-alanine.
L-lysine catabolic process to acetyl-CoA via saccharopine The chemical reactions and pathways resulting in the breakdown of L-lysine into other compounds, including acetyl-CoA, via the intermediate saccharopine.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q5E9N4 AADAT Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial Bos taurus (Bovine) PR
Q9WVM8 Aadat Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial Mus musculus (Mouse) PR
10 20 30 40 50 60
MNYARFITAA SAARNPSPIR TMTDILSRGP KSMISLAGGL PNPNMFPFKT AVITVENGKT
70 80 90 100 110 120
IQFGEEMMKR ALQYSPSAGI PELLSWLKQL QIKLHNPPTI HYPPSQGQMD LCVTSGSQQG
130 140 150 160 170 180
LCKVFEMIIN PGDNVLLDEP AYSGTLQSLH PLGCNIINVA SDESGIVPDS LRDILSRWKP
190 200 210 220 230 240
EDAKNPQKNT PKFLYTVPNG NNPTGNSLTS ERKKEIYELA RKYDFLIIED DPYYFLQFNK
250 260 270 280 290 300
FRVPTFLSMD VDGRVIRADS FSKIISSGLR IGFLTGPKPL IERVILHIQV STLHPSTFNQ
310 320 330 340 350 360
LMISQLLHEW GEEGFMAHVD RVIDFYSNQK DAILAAADKW LTGLAEWHVP AAGMFLWIKV
370 380 390 400 410 420
KGINDVKELI EEKAVKMGVL MLPGNAFYVD SSAPSPYLRA SFSSASPEQM DVAFQVLAQL
IKESL